Cargando…

The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis

The growing research interest in the relationship between health insurance and pharmaceutical innovation is driven by their significant impact on healthcare optimization and pharmaceutical development. The existing literature, however, lacks consensus on this relationship and provides no evidence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chenchen, Song, Xiaoting, Li, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671039/
https://www.ncbi.nlm.nih.gov/pubmed/37998407
http://dx.doi.org/10.3390/healthcare11222916
_version_ 1785140061515284480
author Fan, Chenchen
Song, Xiaoting
Li, Chunyan
author_facet Fan, Chenchen
Song, Xiaoting
Li, Chunyan
author_sort Fan, Chenchen
collection PubMed
description The growing research interest in the relationship between health insurance and pharmaceutical innovation is driven by their significant impact on healthcare optimization and pharmaceutical development. The existing literature, however, lacks consensus on this relationship and provides no evidence of the magnitude of a correlation. In this context, this study employs meta-analysis to explore the extent to which health insurance affects pharmaceutical innovation. It analyzes 202 observations from 14 independent research samples, using the regression coefficient of health insurance on pharmaceutical innovation as the effect size. The results reveal that there is a strong positive correlation between health insurance and pharmaceutical innovation (r = 0.367, 95% CI = [0.294, 0.436]). Public health insurance exhibits a stronger promoting effect on pharmaceutical innovation than commercial health insurance. The relationship between health insurance and pharmaceutical innovation is moderated by the country of sample origin, data range, journal type, journal impact factor, type of health insurance, and research perspective. Our research findings further elucidate the relationship mechanism between health insurance and pharmaceutical innovation, providing a valuable reference for future explorations in pharmaceutical fields.
format Online
Article
Text
id pubmed-10671039
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106710392023-11-07 The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis Fan, Chenchen Song, Xiaoting Li, Chunyan Healthcare (Basel) Article The growing research interest in the relationship between health insurance and pharmaceutical innovation is driven by their significant impact on healthcare optimization and pharmaceutical development. The existing literature, however, lacks consensus on this relationship and provides no evidence of the magnitude of a correlation. In this context, this study employs meta-analysis to explore the extent to which health insurance affects pharmaceutical innovation. It analyzes 202 observations from 14 independent research samples, using the regression coefficient of health insurance on pharmaceutical innovation as the effect size. The results reveal that there is a strong positive correlation between health insurance and pharmaceutical innovation (r = 0.367, 95% CI = [0.294, 0.436]). Public health insurance exhibits a stronger promoting effect on pharmaceutical innovation than commercial health insurance. The relationship between health insurance and pharmaceutical innovation is moderated by the country of sample origin, data range, journal type, journal impact factor, type of health insurance, and research perspective. Our research findings further elucidate the relationship mechanism between health insurance and pharmaceutical innovation, providing a valuable reference for future explorations in pharmaceutical fields. MDPI 2023-11-07 /pmc/articles/PMC10671039/ /pubmed/37998407 http://dx.doi.org/10.3390/healthcare11222916 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fan, Chenchen
Song, Xiaoting
Li, Chunyan
The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title_full The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title_fullStr The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title_full_unstemmed The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title_short The Relationship between Health Insurance and Pharmaceutical Innovation: An Empirical Study Based on Meta-Analysis
title_sort relationship between health insurance and pharmaceutical innovation: an empirical study based on meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671039/
https://www.ncbi.nlm.nih.gov/pubmed/37998407
http://dx.doi.org/10.3390/healthcare11222916
work_keys_str_mv AT fanchenchen therelationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis
AT songxiaoting therelationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis
AT lichunyan therelationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis
AT fanchenchen relationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis
AT songxiaoting relationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis
AT lichunyan relationshipbetweenhealthinsuranceandpharmaceuticalinnovationanempiricalstudybasedonmetaanalysis